Allarity Therapeutics, Inc. Quarterly Debt-to-equity in % from Q2 2022 to Q2 2024

Taxonomy & unit: ratio: %
Description: Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary: Allarity Therapeutics, Inc. quarterly Debt-to-equity history and growth rate from Q2 2022 to Q2 2024.
Allarity Therapeutics, Inc. Debt-to-equity for the quarter ending June 30, 2024 was 848 %.

Debt-to-equity, Quarterly (%)

Debt-to-equity, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date
Q2 2024	848	+3.04K		Jun 30, 2024
Q1 2024	-484	-1.35K	-156%	Mar 31, 2024
Q4 2023	-593	-821	-360%	Dec 31, 2023
Q3 2023	-780	-953	-552%	Sep 30, 2023
Q2 2023	-2.19K	-2.28K	-2446%	Jun 30, 2023
Q1 2023	863			Mar 31, 2023
Q4 2022	228			Dec 31, 2022
Q3 2022	173			Sep 30, 2022
Q2 2022	93.2			Jun 30, 2022

* An asterisk sign (*) next to the value indicates that the value is likely invalid.